• PEAK Matrix®
    July 16, 2025

    In recent years, life sciences enterprises have reprioritized and overhauled their R&D investments. They now focus on streamlining their pipelines and shifting toward new and large molecules. This transformation has compelled aggressive cost containment initiatives, prompting…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…
  • Thematic Report
    Oct. 12, 2020

    Enterprises are embracing cloud services from diverse vendors to get best-in-class services, mitigate risks, and avoid vendor lock-in. This poses a challenge, as every cloud platform is based on its unique, customized architecture, which is not…